2023年SCMR 4D Flow心血管磁共振共识声明解读OA北大核心CSTPCD
4D Flow cardiovascular magnetic resonance consensus statement of SCMR:2023 update
血流动力学评估对于心血管疾病的诊断和治疗十分重要,四维心血管磁共振血流成像(four-dimensional cardiovascular magnetic resonance flow imaging,4D Flow CMR)可在一次采集中全面、准确地评估血流.2023年心血管磁共振学会(Society for Cardiovascular Magnetic Resonance,SCMR)在2015版4D Flow CMR共识声明的基础上更新发布了新版共识声明,为4D Flow CMR的采集参数的选择、后处理工作流程、整合入临床实践、推荐的出版标准提供建议,并定义了临床中心的最低质量保证和验证标准,以及对其局限性和未来展望进行讨论.笔者对新版共识声明进行解读与分析,旨在为未来4D Flow CMR广泛应用于临床及该领域研究方向提供参考.
Hemodialysis evaluation is important for the diagnosis and treatment of cardiovascular disease.Four-dimensional cardiovascular magnetic resonance flow imaging(4D Flow CMR)can comprehensively and accurately evaluate blood flow.The Society for Cardiovascular Magnetic Resonance(SCMR)issued a new consensus statement in 2023 based on the 2015 4D Flow CMR consensus statement.The consensus includes recommendations provided for 4D Flow CMR acquisition parameter selection,post-processing workflow,integration into clinical practice,publication standards checklist,and definition of minimum quality assurance and validation criteria for clinical centers,as well as the current limitations and future.The author interpreted and analyzed the new version of the consensus statement,aiming to provide reference for the wide clinical application of 4D Flow CMR and the research direction of this field in the future.
贾溪;赵世华
中国医学科学院北京协和医学院 国家心血管病中心 阜外医院磁共振影像科,北京 100037
临床医学
四维心血管磁共振血流成像心血管疾病临床实践科学研究共识声明磁共振成像
four-dimensional cardiovascular magnetic resonance flow imagingcardiovascular diseaseclinical practicescientific researchconsensus statementmagnetic resonance imaging
《磁共振成像》 2024 (003)
基于磁共振多模态成像的肥厚型心肌病微循环障碍的演变机制与危险分层研究
1-6 / 6
National Key R&D Program of China(No.2021YFF0501400,2021YFF0501404);National Natural Science Foundation of China(No.81930044). 国家重点研发项目(编号:2021YFF0501400、2021YFF0501404);国家自然科学基金项目(编号:81930044)
评论